Latest filing published 12 Jan 2023 for PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.).
No signal scores available.
This profile gathers the share dealings of Noah Isidore Davis in PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.). We count 2 filings; the first trade dates from 19 February 2021 and the latest from 5 January 2023.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
On 12 January 2023 came the latest disclosure, a transaction in PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.). Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations